Industry
Biotechnology
SeaStar Medical Holding Corporation, a medical device company, focuses on providing novel solutions and services to treat hyperinflammation and cytokine storm in critically ill patients. The company is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. It is developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure with and without LVAD; myocardial stunning in end stage renal disease; and hepatorenal syndrome. The company is based in Denver, Colorado.
Loading...
Open
1.99
Mkt cap
8.9M
Volume
148K
High
2.04
P/E Ratio
-0.22
52-wk high
42.92
Low
1.96
Div yield
N/A
52-wk low
1.83
Portfolio Pulse from
December 04, 2024 | 1:45 pm
Portfolio Pulse from
November 22, 2024 | 1:45 pm
Portfolio Pulse from
November 12, 2024 | 9:15 pm
Portfolio Pulse from Benzinga Newsdesk
November 01, 2024 | 12:31 pm
Portfolio Pulse from Benzinga Newsdesk
October 23, 2024 | 12:30 pm
Portfolio Pulse from Benzinga Newsdesk
October 22, 2024 | 12:31 pm
Portfolio Pulse from Benzinga Newsdesk
October 18, 2024 | 12:52 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.